{"id":12452,"date":"2024-03-08T16:17:40","date_gmt":"2024-03-08T15:17:40","guid":{"rendered":"https:\/\/iph-multisite.berta-bewegt.ch\/?p=12452"},"modified":"2026-03-03T10:39:34","modified_gmt":"2026-03-03T09:39:34","slug":"medienmitteilung-der-bilaterale-weg-soll-weitergehen","status":"publish","type":"post","link":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-der-bilaterale-weg-soll-weitergehen\/","title":{"rendered":"Communiqu\u00e9 de presse: Poursuivre la voie bilat\u00e9rale"},"content":{"rendered":"\n<p class=\"is-style-paragraph-lead-text\"><strong>Le Conseil f\u00e9d\u00e9ral a adopt\u00e9 aujourd\u2019hui le mandat de n\u00e9gociation avec l\u2019UE et va \u00e0 pr\u00e9sent entamer les n\u00e9gociations. Interpharma s\u2019en f\u00e9licite: les accords bilat\u00e9raux III assurent le libre acc\u00e8s au march\u00e9 int\u00e9rieur europ\u00e9en et placent les relations \u00e9conomiques et politiques avec l\u2019UE sur des bases solides.<\/strong><\/p>\n\n\n\n<p>Dans sa politique europ\u00e9enne, la Suisse a pour but de mettre en place les meilleures conditions possibles pour ses relations avec l\u2019UE. La politique europ\u00e9enne de la Suisse s\u2019appuie depuis 25&nbsp;ans avec succ\u00e8s sur des accords sectoriels bilat\u00e9raux entre la Suisse et l\u2019UE, d\u00e9velopp\u00e9s et approfondis r\u00e9guli\u00e8rement pendant toute cette p\u00e9riode.<\/p>\n\n\n\n<p>D<sup>r<\/sup> Ren\u00e9 Buholzer, directeur d\u2019Interpharma, souligne:<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p><em>\u00abEnviron 40% des exportations de la Suisse proviennent de l\u2019industrie pharmaceutique pratiquant la recherche, dont pr\u00e8s de la moiti\u00e9 vont vers l\u2019UE. Les accords bilat\u00e9raux III assurent le libre acc\u00e8s au march\u00e9 int\u00e9rieur europ\u00e9en et placent les relations \u00e9conomiques et politiques avec l\u2019UE sur des bases solides. C\u2019est un bon signe pour le moteur de croissance de l\u2019\u00e9conomie suisse.\u00bb<\/em><\/p>\n<\/blockquote>\n\n\n\n<p>Principaux points du mandat de n\u00e9gociation du point de vue d\u2019Interpharma:<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong><em>Entamer des n\u00e9gociations avec l\u2019UE permet de mettre l\u2019ARM \u00e0 jour. C\u2019est tr\u00e8s important pour les exportations de l\u2019industrie et pour la s\u00e9curit\u00e9 d\u2019approvisionnement.<\/em><\/strong><\/h2>\n\n\n\n<p>L\u2019ARM entre la Suisse et l\u2019UE \u00e9limine des obstacles techniques au commerce et permet de commercer librement avec l\u2019UE. Au cas o\u00f9 l\u2019ARM ne pourrait plus \u00eatre mis \u00e0 jour, la place pharmaceutique suisse risquerait d\u2019\u00eatre soumise \u00e0 de doubles inspections des sites de recherche et de production ainsi qu\u2019\u00e0 de nouvelles certifications des lots dans l\u2019UE. Des calculs montrent que la disparition de l\u2019ARM avec l\u2019UE entra\u00eenerait des co\u00fbts de plus d\u2019un demi-milliard de francs suisses par ann\u00e9e. De nouveaux obstacles techniques au commerce risqueraient en outre de d\u00e9grader l\u2019acc\u00e8s des patient-e-s suisses \u00e0 des m\u00e9dicaments vitaux.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong><em>La libre circulation des personnes aide \u00e0 acc\u00e9der \u00e0 du personnel qualifi\u00e9 indispensable.<\/em><\/strong><\/h2>\n\n\n\n<p>L\u2019industrie pharmaceutique a particuli\u00e8rement besoin de personnel hautement qualifi\u00e9. Sans personnel \u00e9tranger, la branche pharmaceutique ne pourrait ni faire autant de travaux de recherche, ni produire autant, car malgr\u00e9 des efforts constants de renforcer le march\u00e9 du travail national, celui-ci n\u2019est pas assez grand pour couvrir la forte demande en personnel qualifi\u00e9. Pour ce qui est de la protection des salaires, le niveau actuel est assur\u00e9, d\u2019autres mesures ne sont pas n\u00e9cessaires.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-la-conclusion-des-accords-bilateraux-iii-assure-a-long-terme-la-participation-aux-programmes-de-recherche-de-l-ue\"><strong><em>La conclusion des accords bilat\u00e9raux III assure \u00e0 long terme la participation aux programmes de recherche de l\u2019UE.<\/em><\/strong><\/h2>\n\n\n\n<p>Actuellement, gr\u00e2ce aux r\u00e9seaux internationaux auxquels participe son secteur de la recherche, la Suisse fait partie des pays les plus innovants au monde. L\u2019impact \u00e0 court terme de la non-association au programme de recherche de l\u2019UE a pu \u00eatre partiellement amorti par des financements transitoires, mais \u00e0 long terme, la place de recherche suisse perdra en attractivit\u00e9 si l\u2019association compl\u00e8te au programme Horizon Europe n\u2019est pas assur\u00e9e.<\/p>\n\n\n\n<p><a id=\"_msocom_4\"><\/a><\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Le Conseil f\u00e9d\u00e9ral a adopt\u00e9 aujourd\u2019hui le mandat de n\u00e9gociation avec l\u2019UE et va \u00e0 pr\u00e9sent entamer les n\u00e9gociations. Interpharma s\u2019en f\u00e9licite: les accords bilat\u00e9raux III assurent le libre acc\u00e8s au march\u00e9 int\u00e9rieur europ\u00e9en et placent les relations \u00e9conomiques et politiques avec l\u2019UE sur des bases solides. Dans sa politique europ\u00e9enne, la Suisse a pour [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":3149,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"tags":[131,122],"class_list":["post-12452","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","tag-politique","tag-communique-de-presse"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Communiqu\u00e9 de presse: Poursuivre la voie bilat\u00e9rale - Interpharma<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Communiqu\u00e9 de presse: Poursuivre la voie bilat\u00e9rale - Interpharma\" \/>\n<meta property=\"og:description\" content=\"Le Conseil f\u00e9d\u00e9ral a adopt\u00e9 aujourd\u2019hui le mandat de n\u00e9gociation avec l\u2019UE et va \u00e0 pr\u00e9sent entamer les n\u00e9gociations. Interpharma s\u2019en f\u00e9licite: les accords bilat\u00e9raux III assurent le libre acc\u00e8s au march\u00e9 int\u00e9rieur europ\u00e9en et placent les relations \u00e9conomiques et politiques avec l\u2019UE sur des bases solides. Dans sa politique europ\u00e9enne, la Suisse a pour [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-der-bilaterale-weg-soll-weitergehen\/\" \/>\n<meta property=\"og:site_name\" content=\"Interpharma\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-08T15:17:40+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-03T09:39:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/iph-multisite.berta-bewegt.ch\/wp-content\/uploads\/2024\/03\/CH_EU_generisch-klein-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1731\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"berta_admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"berta_admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-der-bilaterale-weg-soll-weitergehen\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-der-bilaterale-weg-soll-weitergehen\/\"},\"author\":{\"name\":\"berta_admin\",\"@id\":\"https:\/\/iph-multisite.berta-bewegt.ch\/#\/schema\/person\/749c3574947ecc016332eb58d91e45a3\"},\"headline\":\"Communiqu\u00e9 de presse: Poursuivre la voie bilat\u00e9rale\",\"datePublished\":\"2024-03-08T15:17:40+00:00\",\"dateModified\":\"2026-03-03T09:39:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-der-bilaterale-weg-soll-weitergehen\/\"},\"wordCount\":543,\"image\":{\"@id\":\"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-der-bilaterale-weg-soll-weitergehen\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/iph-multisite.berta-bewegt.ch\/wp-content\/uploads\/2024\/03\/CH_EU_generisch-klein-scaled.jpg\",\"keywords\":[\"Politique\",\"Communiqu\u00e9 de presse\"],\"inLanguage\":\"fr-FR\",\"copyrightYear\":\"2024\",\"copyrightHolder\":{\"@id\":\"https:\/\/iph-multisite.berta-bewegt.ch\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-der-bilaterale-weg-soll-weitergehen\/\",\"url\":\"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-der-bilaterale-weg-soll-weitergehen\/\",\"name\":\"Communiqu\u00e9 de presse: Poursuivre la voie bilat\u00e9rale - Interpharma\",\"isPartOf\":{\"@id\":\"https:\/\/iph-multisite.berta-bewegt.ch\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-der-bilaterale-weg-soll-weitergehen\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-der-bilaterale-weg-soll-weitergehen\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/iph-multisite.berta-bewegt.ch\/wp-content\/uploads\/2024\/03\/CH_EU_generisch-klein-scaled.jpg\",\"datePublished\":\"2024-03-08T15:17:40+00:00\",\"dateModified\":\"2026-03-03T09:39:34+00:00\",\"author\":{\"@id\":\"https:\/\/iph-multisite.berta-bewegt.ch\/#\/schema\/person\/749c3574947ecc016332eb58d91e45a3\"},\"breadcrumb\":{\"@id\":\"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-der-bilaterale-weg-soll-weitergehen\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-der-bilaterale-weg-soll-weitergehen\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-der-bilaterale-weg-soll-weitergehen\/#primaryimage\",\"url\":\"https:\/\/iph-multisite.berta-bewegt.ch\/wp-content\/uploads\/2024\/03\/CH_EU_generisch-klein-scaled.jpg\",\"contentUrl\":\"https:\/\/iph-multisite.berta-bewegt.ch\/wp-content\/uploads\/2024\/03\/CH_EU_generisch-klein-scaled.jpg\",\"width\":2560,\"height\":1731},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-der-bilaterale-weg-soll-weitergehen\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Communiqu\u00e9 de presse: Poursuivre la voie bilat\u00e9rale\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/iph-multisite.berta-bewegt.ch\/#website\",\"url\":\"https:\/\/iph-multisite.berta-bewegt.ch\/\",\"name\":\"Interpharma\",\"description\":\"Verband der forschenden Pharmazeutischen Firmen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/iph-multisite.berta-bewegt.ch\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/iph-multisite.berta-bewegt.ch\/#\/schema\/person\/749c3574947ecc016332eb58d91e45a3\",\"name\":\"berta_admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"caption\":\"berta_admin\"},\"sameAs\":[\"https:\/\/iph-multisite.berta-bewegt.ch\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Communiqu\u00e9 de presse: Poursuivre la voie bilat\u00e9rale - Interpharma","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"fr_FR","og_type":"article","og_title":"Communiqu\u00e9 de presse: Poursuivre la voie bilat\u00e9rale - Interpharma","og_description":"Le Conseil f\u00e9d\u00e9ral a adopt\u00e9 aujourd\u2019hui le mandat de n\u00e9gociation avec l\u2019UE et va \u00e0 pr\u00e9sent entamer les n\u00e9gociations. Interpharma s\u2019en f\u00e9licite: les accords bilat\u00e9raux III assurent le libre acc\u00e8s au march\u00e9 int\u00e9rieur europ\u00e9en et placent les relations \u00e9conomiques et politiques avec l\u2019UE sur des bases solides. Dans sa politique europ\u00e9enne, la Suisse a pour [&hellip;]","og_url":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-der-bilaterale-weg-soll-weitergehen\/","og_site_name":"Interpharma","article_published_time":"2024-03-08T15:17:40+00:00","article_modified_time":"2026-03-03T09:39:34+00:00","og_image":[{"width":2560,"height":1731,"url":"https:\/\/iph-multisite.berta-bewegt.ch\/wp-content\/uploads\/2024\/03\/CH_EU_generisch-klein-scaled.jpg","type":"image\/jpeg"}],"author":"berta_admin","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"berta_admin","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-der-bilaterale-weg-soll-weitergehen\/#article","isPartOf":{"@id":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-der-bilaterale-weg-soll-weitergehen\/"},"author":{"name":"berta_admin","@id":"https:\/\/iph-multisite.berta-bewegt.ch\/#\/schema\/person\/749c3574947ecc016332eb58d91e45a3"},"headline":"Communiqu\u00e9 de presse: Poursuivre la voie bilat\u00e9rale","datePublished":"2024-03-08T15:17:40+00:00","dateModified":"2026-03-03T09:39:34+00:00","mainEntityOfPage":{"@id":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-der-bilaterale-weg-soll-weitergehen\/"},"wordCount":543,"image":{"@id":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-der-bilaterale-weg-soll-weitergehen\/#primaryimage"},"thumbnailUrl":"https:\/\/iph-multisite.berta-bewegt.ch\/wp-content\/uploads\/2024\/03\/CH_EU_generisch-klein-scaled.jpg","keywords":["Politique","Communiqu\u00e9 de presse"],"inLanguage":"fr-FR","copyrightYear":"2024","copyrightHolder":{"@id":"https:\/\/iph-multisite.berta-bewegt.ch\/#organization"}},{"@type":"WebPage","@id":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-der-bilaterale-weg-soll-weitergehen\/","url":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-der-bilaterale-weg-soll-weitergehen\/","name":"Communiqu\u00e9 de presse: Poursuivre la voie bilat\u00e9rale - Interpharma","isPartOf":{"@id":"https:\/\/iph-multisite.berta-bewegt.ch\/#website"},"primaryImageOfPage":{"@id":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-der-bilaterale-weg-soll-weitergehen\/#primaryimage"},"image":{"@id":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-der-bilaterale-weg-soll-weitergehen\/#primaryimage"},"thumbnailUrl":"https:\/\/iph-multisite.berta-bewegt.ch\/wp-content\/uploads\/2024\/03\/CH_EU_generisch-klein-scaled.jpg","datePublished":"2024-03-08T15:17:40+00:00","dateModified":"2026-03-03T09:39:34+00:00","author":{"@id":"https:\/\/iph-multisite.berta-bewegt.ch\/#\/schema\/person\/749c3574947ecc016332eb58d91e45a3"},"breadcrumb":{"@id":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-der-bilaterale-weg-soll-weitergehen\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-der-bilaterale-weg-soll-weitergehen\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-der-bilaterale-weg-soll-weitergehen\/#primaryimage","url":"https:\/\/iph-multisite.berta-bewegt.ch\/wp-content\/uploads\/2024\/03\/CH_EU_generisch-klein-scaled.jpg","contentUrl":"https:\/\/iph-multisite.berta-bewegt.ch\/wp-content\/uploads\/2024\/03\/CH_EU_generisch-klein-scaled.jpg","width":2560,"height":1731},{"@type":"BreadcrumbList","@id":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-der-bilaterale-weg-soll-weitergehen\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/"},{"@type":"ListItem","position":2,"name":"Communiqu\u00e9 de presse: Poursuivre la voie bilat\u00e9rale"}]},{"@type":"WebSite","@id":"https:\/\/iph-multisite.berta-bewegt.ch\/#website","url":"https:\/\/iph-multisite.berta-bewegt.ch\/","name":"Interpharma","description":"Verband der forschenden Pharmazeutischen Firmen","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/iph-multisite.berta-bewegt.ch\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/iph-multisite.berta-bewegt.ch\/#\/schema\/person\/749c3574947ecc016332eb58d91e45a3","name":"berta_admin","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","caption":"berta_admin"},"sameAs":["https:\/\/iph-multisite.berta-bewegt.ch"]}]}},"_links":{"self":[{"href":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/wp-json\/wp\/v2\/posts\/12452","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/wp-json\/wp\/v2\/comments?post=12452"}],"version-history":[{"count":1,"href":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/wp-json\/wp\/v2\/posts\/12452\/revisions"}],"predecessor-version":[{"id":12453,"href":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/wp-json\/wp\/v2\/posts\/12452\/revisions\/12453"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/wp-json\/wp\/v2\/media\/3149"}],"wp:attachment":[{"href":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/wp-json\/wp\/v2\/media?parent=12452"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/wp-json\/wp\/v2\/tags?post=12452"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}